ADVERTISEMENT

 

OAB Track

AUA2015 Webcasts

Educational grant support provided by:

  • Allergan, Inc.
  • Astellas
  • Medtronic

A Decade of Pharmacotherapy for OAB: What Have We Learned? Claim CME Activity

Introduction: Goals & Objectives

Speaker: Alan J. Wein, MD, PhD


Origin of the Term OAB


Critical Look at the Term

Speaker: Jerry G. Blaivas, MD


Anticholinergics: Have They Stood the Test of Time


Clinical Trials vs. Real World Experience of Anticholinergics


Beta 3 Agonists: Will it Fill the Void?

Speaker: Victor W. Nitti, MD


What is New in the Pipeline?


Concluding Remarks

Speaker: Alan J. Wein, MD, PhD


Primary Care Update in Urology Claim CME Activity

Primary Care Perspective on Overactive Bladder in the Geriatric Patient

Faculty: Tomas L. Griebling, MD, MPH


Botulinum Toxin: Why Use It, How to Do It, What are the Results? Claim CME Activity

021IC: Botulinum Toxin: Why Use It, How to Do It, What are the Results?

Director: Michael B. Chancellor, MD